Global & Commercial Milestones

2025

• Winner (Grand Prize) at the TIPA ValueUP Final Demo Day
• Selected for the 2025 “BIG WAVE” IR Program by the Incheon Center for Creative Economy & Innovation (CCEI)
• Advanced to the finals of the Southeast Asia Golden Panda Global Innovation Startup Competition
• Selected as a participating company for China Invest Week 2025 (Shanghai)
• Received a Ministerial Commendation (Ministry of SMEs and Startups) in the Startup Activation category at the 2025 Venture Startup Promotion Merit Awards

2024

• PERIMEDI^® (peri-implantitis treatment) — Phase III clinical trial completed

GrowthClinical Progress & Government-backed Support

2023

• Investment from POSCO Technology Investment

• Selected for the TIPS Overseas Marketing Support Program

• PERIMEDI® (peri-implantitis treatment) — Phase III clinical trial ongoing

2022

• Selected as a finalist for Korea’s “Baby Unicorn” program
  (Support package: market expansion funding KRW 300 million; special guarantee up to KRW 5 billion; R&D funding KRW 2 billion; policy funds KRW 10 billion available.)

Technology & Investment Milestones

2021

• Received investment from HB Investment

• Received investment from CKD Venture Capital

• Received investment from A Ventures

• Received investment from Korea Venture Investment Corp. (KVIC) (Korea Venture Investment Corporation)

2020

• Completed a technology transfer agreement with Yuhan Corporation

• Completed a pharmaceutical supply agreement with Thailand’s NueMedi

• Selected for the Startup Do-yak Package (government-backed startup acceleration program)

Foundation & Early Milestones

2019

• Completed KRW 300 million investment from POSCO RCPS

• Filed trademark registrations

• Selected for the TIPS Startup Commercialization Program

• Certified as a Venture Company

• Certified as an In-house Corporate R&D Center

• Purchased a GMP manufacturing facility/building

• Received investment from HB Investment

• Received investment from KB Securities

• Received investment from CKD Venture Capital

• Received investment from Shinhan Capital

2018

• Team formation

• Selected for the 2018 University Startup Leader Program (Soongsil University) — Item commercialization track

• Incorporated

• Participated in SIDEX (Seoul International Dental Exhibition & Scientific Congress)

• Completed two patent technology transfer agreements (Kangwon National University, Dental Engineering Research Institute)

• Accepted into the SBA Accelerating Program (Seoul Business Agency)

• Won “Best Idea Award” at POSCO IMP

Years of innovation never stood still. Now, MXBIO, Inc. is shaping what’s next in global biotech.